Bronchiolitis Obliterans – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the industry
Empower your strategies with our Bronchiolitis Obliterans – Drugs In Development, 2024 report and make more profitable business decisions.
Bronchiolitis Obliterans also known as popcorn lung is a rare chronic disease causing the obstruction of small airways thereby declining the activity of lungs. It is one of the complications after lung transplant and hematopoietic stem cell transplantation. Inhalation of toxic chemicals like acetaldehyde, formaldehyde, ammonia, chlorine, nitrogen oxides etc. and associated with autoimmune disorders. When exposed to toxins or certain infections bronchioles becomes injured causing the build-up of scar tissue and leading to disability in absorbing oxygen. The most common symptoms associated are SOB, dry cough, fatigue, wheezing, skin rash etc. Diagnosed based on the symptoms and imaging studies, CT scan, chest X-ray, lung biopsy if needed. If caused because of transplantation complication immunosuppressants are prescribed, corticosteroids in combination and other symptomatic treatment provided.
The Bronchiolitis Obliterans drugs in development market research report provide comprehensive information on the therapeutics under development for Bronchiolitis Obliterans, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Bronchiolitis Obliterans and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Bronchiolitis Obliterans | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 10 molecules, with 10 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Bronchiolitis Obliterans therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Bronchiolitis Obliterans pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Bronchiolitis Obliterans treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.